Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

[Neurology].

Sokolov AA, Rossetti AO, Michel P, Benninger D, Nater B, Wider C, Hirt L, Kuntzer T, Démonet JF, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2016 Jan 13;12(500):62, 64-6. French.

PMID:
26946707
2.

Rare genetic variants support mitochondrial dysfunction in Lewy body disorders.

Wider C, Mouradian MM.

Neurology. 2015 Dec 8;85(23):2002-3. doi: 10.1212/WNL.0000000000002182. Epub 2015 Nov 11. No abstract available.

PMID:
26561295
3.

[Trajectory of a patient with deep brain stimulation (DBS)].

Horvath J, Chiuvé SC, Gronchi-Perrin A, Zacharia A, Wider C, Fleury V.

Rev Med Suisse. 2015 Apr 29;11(472):968-71. French.

PMID:
26062222
4.

Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.

Puschmann A, Brighina L, Markopoulou K, Aasly J, Chung SJ, Frigerio R, Hadjigeorgiou G, Kõks S, Krüger R, Siuda J, Wider C, Zesiewicz TA, Maraganore DM.

Parkinsonism Relat Disord. 2015 Jul;21(7):675-82. doi: 10.1016/j.parkreldis.2015.04.029. Epub 2015 May 1. Review.

PMID:
25952959
5.

PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain.

Spatola M, Wider C, Kuntzer T, Croquelois A.

BMC Neurol. 2015 Apr 16;15:55. doi: 10.1186/s12883-015-0310-8.

6.

[News in neurology 2014].

Tsetsou S, Rossetti AO, Michel P, Hirt L, Wider C, Benninger D, Kuntzer T, Nater B, Démonet JF, Schluep M, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2015 Jan 14;11(456-457):91-6. French.

PMID:
25799659
7.

p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder.

Suter MR, Bhuiyan ZA, Laedermann CJ, Kuntzer T, Schaller M, Stauffacher MW, Roulet E, Abriel H, Decosterd I, Wider C.

Anesthesiology. 2015 Feb;122(2):414-23. doi: 10.1097/ALN.0000000000000476.

8.

GNAL deletion as a probable cause of dystonia in a patient with the 18p- syndrome.

Esposito F, Addor MC, Humm AM, Vingerhoets F, Wider C.

Parkinsonism Relat Disord. 2014 Mar;20(3):351-2. doi: 10.1016/j.parkreldis.2013.12.005. Epub 2013 Dec 25. No abstract available.

PMID:
24405754
9.

Hereditary diffuse leukoencephalopathy with axonal spheroids: more than just a rare disease.

Wider C, Wszolek ZK.

Neurology. 2014 Jan 14;82(2):102-3. doi: 10.1212/WNL.0000000000000026. Epub 2013 Dec 13. No abstract available.

PMID:
24336229
10.

Genetics of Parkinson's disease: the yield.

Spatola M, Wider C.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S35-8. doi: 10.1016/S1353-8020(13)70011-7. Review.

PMID:
24262184
11.

Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.

Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, Borjesson-Hanson A, Uitti RJ, Ross OA, Stoessl AJ, Rademakers R, Josephs KA, Dickson DW, Broderick D, Wszolek ZK.

Parkinsonism Relat Disord. 2013 Oct;19(10):869-77. doi: 10.1016/j.parkreldis.2013.05.013. Epub 2013 Jun 17.

12.

Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's disease.

Fleury V, Wider C, Horvath J, Zacharia A, Bally J, Pollak P, Pollo C, Vingerhoets FJ, Burkhard PR.

Parkinsonism Relat Disord. 2013 Jul;19(7):707-8. doi: 10.1016/j.parkreldis.2013.04.002. Epub 2013 Apr 24. No abstract available.

PMID:
23623008
13.

CSF1R mutations link POLD and HDLS as a single disease entity.

Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, Nelson PT, Clark HB, Wszolek ZK, Dickson DW, Knopman DS, Rademakers R.

Neurology. 2013 Mar 12;80(11):1033-40. doi: 10.1212/WNL.0b013e31828726a7. Epub 2013 Feb 13.

14.

Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?.

Spatola M, Jeannet PY, Pollo C, Wider C, Labrum R, Rossetti AO.

Eur Neurol. 2013;69(2):119-21. doi: 10.1159/000345132. Epub 2012 Nov 29.

15.

MRI characteristics and scoring in HDLS due to CSF1R gene mutations.

Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, Broderick D, Wszolek ZK.

Neurology. 2012 Aug 7;79(6):566-74. doi: 10.1212/WNL.0b013e318263575a. Epub 2012 Jul 25.

16.

An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.

Wider C, Ross OA, Nishioka K, Heckman MG, Vilariño-Güell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):424-9. doi: 10.1136/jnnp-2011-301413. Epub 2012 Jan 30.

17.

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.

Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, Van Gerpen JA, Meschia JF, Levy S, Broderick DF, Graff-Radford N, Ross OA, Miller BB, Swerdlow RH, Dickson DW, Wszolek ZK.

Nat Genet. 2011 Dec 25;44(2):200-5. doi: 10.1038/ng.1027.

18.

Overview of primary monogenic dystonia.

Spatola M, Wider C.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S158-61. doi: 10.1016/S1353-8020(11)70049-9. Review.

PMID:
22166420
19.

Genetics of essential tremor.

Jasinska-Myga B, Wider C.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S138-9. doi: 10.1016/S1353-8020(11)70043-8. Review.

PMID:
22166413
20.

Loss of ability to work and ability to live independently in Parkinson's disease.

Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ.

Parkinsonism Relat Disord. 2012 Feb;18(2):130-5. doi: 10.1016/j.parkreldis.2011.08.022. Epub 2011 Oct 4.

21.

VPS35 mutations in Parkinson disease.

Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Ghika J, Hentati F, Krygowska-Wajs A, Lynch T, Melamed E, Rajput A, Rajput AH, Solida A, Wu RM, Uitti RJ, Wszolek ZK, Vingerhoets F, Farrer MJ.

Am J Hum Genet. 2011 Jul 15;89(1):162-7. doi: 10.1016/j.ajhg.2011.06.001. Erratum in: Am J Hum Genet. 2011 Aug 12;89(2):347.

22.

Death-associated protein kinase 1 variation and Parkinson's disease.

Dachsel JC, Wider C, Vilariño-Güell C, Aasly JO, Rajput A, Rajput AH, Lynch T, Craig D, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Heckman MG, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Aug;18(8):1090-3. doi: 10.1111/j.1468-1331.2010.03255.x. Epub 2010 Nov 30.

PMID:
21749573
23.

Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis.

Niederhauser J, Lobrinus JA, Ochsner F, Wider C, Fellmann F, Yerly P, Antonino AT, Saraiva MJ, Moradpour D, Kuntzer T.

Transplantation. 2011 Mar 27;91(6):e40-2. doi: 10.1097/TP.0b013e318208c0a2. No abstract available.

PMID:
21383601
24.

SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.

Wider C, Vilariño-Güell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Jun;18(6):876-81. doi: 10.1111/j.1468-1331.2010.03297.x. Epub 2010 Dec 15.

PMID:
21159074
25.

Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.

Jasinska-Myga B, Kachergus J, Vilariño-Güell C, Wider C, Soto-Ortolaza AI, Kefi M, Middleton LT, Ishihara-Paul L, Gibson RA, Amouri R, Yahmed SB, Sassi SB, Zouari M, El Euch G, Ross OA, Hentati F, Farrer MJ.

Mov Disord. 2010 Oct 15;25(13):2052-8. doi: 10.1002/mds.23283.

PMID:
20721913
26.

Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.

Nishioka K, Wider C, Vilariño-Güell C, Soto-Ortolaza AI, Lincoln SJ, Kachergus JM, Jasinska-Myga B, Ross OA, Rajput A, Robinson CA, Ferman TJ, Wszolek ZK, Dickson DW, Farrer MJ.

Arch Neurol. 2010 Aug;67(8):970-5. doi: 10.1001/archneurol.2010.177.

27.

Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.

Aasly JO, Vilariño-Güell C, Dachsel JC, Webber PJ, West AB, Haugarvoll K, Johansen KK, Toft M, Nutt JG, Payami H, Kachergus JM, Lincoln SJ, Felic A, Wider C, Soto-Ortolaza AI, Cobb SA, White LR, Ross OA, Farrer MJ.

Mov Disord. 2010 Oct 15;25(13):2156-63. doi: 10.1002/mds.23265.

28.

Genetics of Parkinson disease and essential tremor.

Wider C, Ross OA, Wszolek ZK.

Curr Opin Neurol. 2010 Aug;23(4):388-93. doi: 10.1097/WCO.0b013e32833b1f4c. Review.

29.

Association of pyridoxal kinase and Parkinson disease.

Vilariño-Güell C, Wider C, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Ann Neurol. 2010 Mar;67(3):409-11. doi: 10.1002/ana.21962. No abstract available.

PMID:
20373354
30.

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease.

Vilariño-Güell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ.

Neurogenetics. 2010 Oct;11(4):401-8. doi: 10.1007/s10048-010-0241-x. Epub 2010 Apr 6.

31.

Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation.

Wider C, Dickson DW, Wszolek ZK.

Neurodegener Dis. 2010;7(1-3):175-9. doi: 10.1159/000289232. Epub 2010 Mar 3.

32.

Clinical implications of gene discovery in Parkinson's disease and parkinsonism.

Wider C, Foroud T, Wszolek ZK.

Mov Disord. 2010;25 Suppl 1:S15-20. doi: 10.1002/mds.22723.

PMID:
20187245
33.

Depression in Parkinson's disease.

Jasinska-Myga B, Putzke JD, Wider C, Wszolek ZK, Uitti RJ.

Can J Neurol Sci. 2010 Jan;37(1):61-6.

34.

Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.

Nishioka K, Vilariño-Güell C, Cobb SA, Kachergus JM, Ross OA, Wider C, Gibson RA, Hentati F, Farrer MJ.

Neurosci Lett. 2010 Jun 21;477(2):57-60. doi: 10.1016/j.neulet.2009.11.066. Epub 2009 Nov 27.

35.

Association of the MAPT locus with Parkinson's disease.

Wider C, Vilariño-Güell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2010 Mar;17(3):483-6. doi: 10.1111/j.1468-1331.2009.02847.x. Epub 2009 Nov 12.

36.

GCH1 in early-onset Parkinson's disease.

Cobb SA, Wider C, Ross OA, Mata IF, Adler CH, Rajput A, Rajput AH, Wu RM, Hauser R, Josephs KA, Carr J, Gwinn K, Heckman MG, Aasly JO, Lynch T, Uitti RJ, Wszolek ZK, Kapatos G, Farrer MJ.

Mov Disord. 2009 Oct 30;24(14):2070-5. doi: 10.1002/mds.22729.

PMID:
19735094
37.

Elucidating the genetics and pathology of Perry syndrome.

Wider C, Dachsel JC, Farrer MJ, Dickson DW, Tsuboi Y, Wszolek ZK.

J Neurol Sci. 2010 Feb 15;289(1-2):149-54. doi: 10.1016/j.jns.2009.08.044. Epub 2009 Sep 4.

38.

A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.

Nishioka K, Kefi M, Jasinska-Myga B, Wider C, Vilariño-Güell C, Ross OA, Heckman MG, Middleton LT, Ishihara-Paul L, Gibson RA, Amouri R, Ben Yahmed S, Ben Sassi S, Zouari M, El Euch G, Farrer MJ, Hentati F.

J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):391-5. doi: 10.1136/jnnp.2009.185231. Epub 2009 Sep 2.

PMID:
19726410
39.

LINGO1 rs9652490 is associated with essential tremor and Parkinson disease.

Vilariño-Güell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ.

Parkinsonism Relat Disord. 2010 Feb;16(2):109-11. doi: 10.1016/j.parkreldis.2009.08.006. Epub 2009 Aug 31.

40.

Calbindin-1 association and Parkinson's disease.

Soto-Ortolaza AI, Behrouz B, Wider C, Vilariño-Güell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2010 Feb;17(2):208-11. doi: 10.1111/j.1468-1331.2009.02769.x. Epub 2009 Aug 5.

PMID:
19674066
41.

GCH1 expression in human cerebellum from healthy individuals is not gender dependent.

Wider C, Lincoln S, Dachsel JC, Kapatos G, Heckman MG, Diehl NN, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Dickson DW, Wszolek ZK, Farrer MJ.

Neurosci Lett. 2009 Oct 2;462(1):73-5. doi: 10.1016/j.neulet.2009.06.082. Epub 2009 Jun 30.

42.

Characterization of DCTN1 genetic variability in neurodegeneration.

Vilariño-Güell C, Wider C, Soto-Ortolaza AI, Cobb SA, Kachergus JM, Keeling BH, Dachsel JC, Hulihan MM, Dickson DW, Wszolek ZK, Uitti RJ, Graff-Radford NR, Boeve BF, Josephs KA, Miller B, Boylan KB, Gwinn K, Adler CH, Aasly JO, Hentati F, Destée A, Krygowska-Wajs A, Chartier-Harlin MC, Ross OA, Rademakers R, Farrer MJ.

Neurology. 2009 Jun 9;72(23):2024-8. doi: 10.1212/WNL.0b013e3181a92c4c.

43.

Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?

Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wszolek ZK.

Neurology. 2009 Jun 2;72(22):1953-9. doi: 10.1212/WNL.0b013e3181a826c0. Review.

44.

GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease.

Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Baker M, Rademakers R, Uitti RJ, Farrer MJ, Ross OA, Wszolek ZK.

Eur J Neurol. 2009 Aug;16(8):909-11. doi: 10.1111/j.1468-1331.2009.02621.x. Epub 2009 Mar 31.

PMID:
19473366
45.

Phactr2 and Parkinson's disease.

Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K, Aasly JO, Gibson JM, Lynch T, Rajput A, Rajput ML, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Neurosci Lett. 2009 Mar 27;453(1):9-11. doi: 10.1016/j.neulet.2009.02.009. Epub 2009 Feb 10.

46.

Familial idiopathic basal ganglia calcification: a challenging clinical-pathological correlation.

Wider C, Dickson DW, Schweitzer KJ, Broderick DF, Wszolek ZK.

J Neurol. 2009 May;256(5):839-42. doi: 10.1007/s00415-009-5025-6. Epub 2009 Mar 1. No abstract available.

47.

DCTN1 mutations in Perry syndrome.

Farrer MJ, Hulihan MM, Kachergus JM, Dächsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilariño-Güell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK.

Nat Genet. 2009 Feb;41(2):163-5. doi: 10.1038/ng.293. Epub 2009 Jan 11.

48.

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.

Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Mov Disord. 2009 Feb 15;24(3):455-9. doi: 10.1002/mds.22442.

49.

Movement disorders: insights into mechanisms and hopes for treatment.

Wider C, Wszolek ZK.

Lancet Neurol. 2009 Jan;8(1):8-10. doi: 10.1016/S1474-4422(08)70273-4. Review. No abstract available.

PMID:
19081502
50.

Clinical genetics of Parkinson's disease and related disorders.

Wider C, Wszolek ZK.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5. Review.

PMID:
18267241

Supplemental Content

Support Center